Abbott Acquires A Future For Its Diabetes Care Business; Where’s Bayer?

Access to a development partnership with insulin infusion pump manufacturer Smiths Medical could prove a critical component of Abbott Labs' $1.2 bil. purchase of diabetes management firm TheraSense